Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.36 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.36 |
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.36 |
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL1444204 | 1.00 | KMT2A (0.46) | KMT2ALMNAHTTALDH1A1KDM4E | |
| Water SCHEMBL20475938 | 1.00 | KMT2A (0.46) | KMT2ALMNAHTTALDH1A1KDM4E | |
| Water SCHEMBL6936586 | 1.00 | KMT2A (0.46) | KMT2ALMNAHTTALDH1A1KDM4E | |
| SCHEMBL72732 | 0.98 | KMT2A (0.47) | KMT2ALMNAHTTALDH1A1KDM4E | |
| SCHEMBL20495576 | 0.98 | KMT2A (0.47) | KMT2ALMNAHTTALDH1A1KDM4E | |
| Water SCHEMBL15641759 | 0.97 | KMT2A (0.44) | KMT2ALMNAHTTALDH1A1KDM4E | |
| Water SCHEMBL2725823 | 0.94 | KMT2A (0.41) | KMT2ALMNAHTTALDH1A1KDM4E | |
| SCHEMBL555799 | 0.92 | KMT2A (0.42) | KMT2ALMNAHTTALDH1A1KDM4E | |
| Water SCHEMBL955959 | 0.89 | KMT2A (0.43) | KMT2AHTTKDM4EMAPTATM | |
| Water SCHEMBL1061545 | 0.89 | KMT2A (0.43) | KMT2AHTTKDM4EMAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6574 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101351-A1 | METHOD FOR PREPARING LIPID NANOPARTICLES | 주식회사 테르나테라퓨틱스 | 2026-05-15 | — | — | WO | claimed |
| EP-4739416-A1 | METHOD OF PURIFICATION | CSL Behring AG (CH) | 2026-05-13 | — | — | EP | claimed |
| EP-3986465-B1 | SITE-SPECIFIC, KINETICALLY INERT CONJUGATION OF LABELS AND/OR CARRIERS TO TARGET MOLECULES SUCH AS HIS-TAGGED PROTEINS VIA METAL COMPLEX REAGENTS | MAX PLANCK GESELLSCHAFT (DE) | 2026-05-13 | — | — | EP | claimed |
| EP-4739992-A1 | DETECTION OF TARGET MOLECULES IN DRIED BIOLOGIC MATRICES | SomaLogic Operating Co., Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | claimed |
| EP-4724588-A1 | A METHOD OF ENHANCED SEPARATION OF FULL ADENO-ASSOCIATED VIRUS (AAV) CAPSIDS | Sartorius BIA Separations d.o.o. (SI) | 2026-04-15 | — | — | EP | claimed |
| US-20260085339-A1 | PATHOGEN TESTING DEVICE AND METHOD | RT MICRODX INC (US) | 2026-03-26 | — | — | US | claimed |
| US-12582670-B2 | Lignin solvation using aqueous biologically compatible buffers | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-03-24 | — | — | US | claimed |
| US-20260077091-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| US-20260077090-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| EP-0465510-A1 | A STABLE HEMOGLOBIN REFERENCE SOLUTION. | BIONOSTICS INC (US) | 1992-01-15 | — | — | EP | claimed |
| CN-1014547-B | VIABLE CELL LABELLING | SMITHKLINE BECKMAN CORP (US) | 1991-10-30 | — | — | CN | claimed |
| US-5045529-A | Tonometric fluid for blood gas and co-oximetry instruments | BIONOSTICS, INC. (US) | 1991-09-03 | — | — | US | claimed |
| WO-1990011527-A1 | A STABLE HEMOGLOBIN REFERENCE SOLUTION | BIONOSTICS, INC. (US) | 1990-10-04 | — | — | WO | claimed |
| US-4914041-A | CONTAINING HEPARIN | BECKMAN INSTRUMENTS, INC. (US) | 1990-04-03 | — | — | US | claimed |
| EP-0354954-A1 | REAGENT AND METHOD FOR DETECTING RHEUMATOID FACTOR. | BECKMAN INSTRUMENTS INC (US) | 1990-02-21 | — | — | EP | claimed |
| WO-1989007765-A1 | NOVEL BUFFER AND METHOD FOR DETECTING RHEUMATOID FACTOR | BECKMAN INSTRUMENTS, INC. (US) | 1989-08-24 | — | — | WO | claimed |
| US-4783401-A | CYANINE DYE, OSMOLARITY REGULATOR | SMITHKLINE BECKMAN CORPORATION (US) | 1988-11-08 | — | — | US | claimed |
| CN-87107216-A | VIABLE CELL LABELLING | — | 1988-05-11 | — | — | CN | claimed |
| EP-0266194-A2 | Viable cell labelling | Zynaxis Inc. (US) | 1988-05-04 | — | — | EP | claimed |